Agent Orange Linked to Kidney Cancer: Study
SATURDAY, May 14 (HealthDay News) -- There appears to be a link
between Agent Orange and kidney cancer in U.S. veterans exposed to
the herbicide in Vietnam, a new study suggests.
Smoking Might Raise Odds for Prostate Cancer's Return
MONDAY, May 16 (HealthDay News) -- In men who've had their
prostate surgically removed due to prostate cancer, smoking seems
linked to a rise in blood levels of prostate specific antigen (PSA)
-- a measure of the risk of cancer recurrence.
Poor Sleep Tied to Incontinence, Impotence
SATURDAY, May 14 (HealthDay News) -- Sleep problems are
associated with erectile dysfunction and urologic conditions such
as incontinence, according to the results of two new studies.
Chemical in Smoke May Pose Health Risk
MONDAY, May 16 (HealthDay News) -- A chemical in smoke from
cigarettes, forest fires and cooking/heating fires may pose a
health risk, a new study indicates.
ICU Patients May Benefit From 'Telemedicine'
MONDAY, May 16 (HealthDay News) -- Telemedicine -- the care of
patients by health care professionals located remotely -- may
benefit intensive care unit patients, new U.S. research shows.
Binge Drinking Tied to Memory Loss in College Students: Study
MONDAY, May 16 (HealthDay News) -- A new Spanish study links
binge drinking in college students to a lowered ability to remember
lists of words, although the research doesn't prove alcohol is at
fault and the drinkers did fine on a separate memory test.
PSA Test Could Be Improved to Spot Prostate Cancer
MONDAY, May 16 (HealthDay News) -- Amid the controversy swirling
around the value of PSA testing as a screen for prostate cancer,
new evidence emerges that there may be ways to fine-tune the
screening so it benefits more men, while avoiding unnecessary
biopsies and treatment.
New Drug Extends Life a Bit in Advanced Prostate Cancer
MONDAY, May 16 (HealthDay News) -- For men with advanced
hormone-resistant prostate cancer who have also failed
chemotherapy, the new drug Zytiga (abiraterone acetate) along with
the steroid prednisone appears to increase survival modestly, a new
study reports.
GPs Lack Accuracy in Spotting Skin Cancers: Study
MONDAY, May 16 (HealthDay News) -- When general doctors refer
patients to a specialist to investigate a suspicious skin lesion,
it's more often another lesion that turns out to be cancerous, a
new study finds.
Victrelis Approved for Chronic Hepatitis C
MONDAY, May 16 (HealthDay News) -- Victrelis (boceprevir) has
been approved by the U.S. Food and Drug Administration to treat
chronic hepatitis C, in tandem with the two additional drugs,
pegylated interferon alfa and ribavirin.